Literature DB >> 26113581

An unusual cause of febrile hepatitis.

Teresa Stelzer1, Sibylle Kohler2, Ewerton Marques Maggio3, Ludwig Theodor Heuss1.   

Abstract

We describe the case of a 51-year-old man with recently diagnosed ulcerative colitis who developed fever and elevated liver enzymes as well as cholestasis a few weeks after starting treatment with mesalazine. As no obvious cause was found and fever persisted, liver biopsy was performed and revealed granulomatous hepatitis. The patient recovered completely after cessation of mesalazine, so that a drug-induced granulomatous hepatitis after exclusion of other differential diagnoses in an extensive work up was assumed. The present case demonstrates that even though drug-induced liver injury due to mesalazine is rare, it should be considered in unclear cases and lead to prompt discontinuation of mesalazine. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26113581      PMCID: PMC4488648          DOI: 10.1136/bcr-2014-205857

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  Cholestasis associated with mesalazine therapy in a patient with Crohn's disease.

Authors:  B Stoschus; M Meybehm; U Spengler; C Scheurlen; T Sauerbruch
Journal:  J Hepatol       Date:  1997-02       Impact factor: 25.083

2.  Granulomatous hepatitis associated with salicylazosulfapyridine therapy.

Authors:  J P Callen; R M Soderstrom
Journal:  South Med J       Date:  1978-09       Impact factor: 0.954

3.  Mesalamine-induced granulomatous hepatitis.

Authors:  M Braun; G M Fraser; M Kunin; F Salamon; R Tur-Kaspa
Journal:  Am J Gastroenterol       Date:  1999-07       Impact factor: 10.864

Review 4.  Granulomatous liver disease.

Authors:  Steven L Flamm
Journal:  Clin Liver Dis       Date:  2012-05       Impact factor: 6.126

5.  Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

Authors:  R A J Ransford; M J S Langman
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

6.  Reversible sulfasalazine-induced granulomatous hepatitis.

Authors:  A Namias; R Bhalotra; M Donowitz
Journal:  J Clin Gastroenterol       Date:  1981-06       Impact factor: 3.062

Review 7.  Drug-induced liver injury: is it somehow foreseeable?

Authors:  Giovanni Tarantino; Matteo Nicola Dario Di Minno; Domenico Capone
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

Review 8.  Hepatic safety of antibiotics used in primary care.

Authors:  Raúl J Andrade; Paul M Tulkens
Journal:  J Antimicrob Chemother       Date:  2011-05-17       Impact factor: 5.790

9.  Liver disorders in inflammatory bowel disease.

Authors:  Victor Uko; Suraj Thangada; Kadakkal Radhakrishnan
Journal:  Gastroenterol Res Pract       Date:  2012-02-15       Impact factor: 2.260

10.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

View more
  1 in total

Review 1.  Recent Advances in the Histopathology of Drug-Induced Liver Injury.

Authors:  David E Kleiner
Journal:  Surg Pathol Clin       Date:  2018-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.